point of_care_testIn 2008 members from the International Federation of Biomedical Laboratory Science (IFBLS) and the European Association for Professions in Biomedical Science (EPBS) took on the task to prepare guidelines for our members on Point of Care Testing.  

The Guidelines for Point of Care Testing and the EPBS Policy Statement approved at their annual meeting in October 2009 in Oslo were distributed as part of the Congress documents prior to Congress. Both documents serve an important purpose and were unanimously adopted by GAD 2010 NairobiKenya.

 

IFBLS Position Paper on Point of Care Testing was adopted by the IFBLS GAD 2018 in Florence, Italy

IFBLS Position Paper - Point of Care Testing

Point of Care Testing is diagnostic testing that is performed near or at the site of the patient, outside of the biomedical laboratory setting, and normally performed by non-biomedical laboratory professionals. Point of Care Testing may reduce timeframes between diagnosis and treatment, improve patient outcomes and reduce hospital lengths of stay.

It is the position of IFBLS that:

Point of Care Testing should be considered an adjunct to testing performed in biomedical laboratories and an important component of Biomedical Laboratory Science Scope of Practice.
Biomedical Laboratory Scientists must ensure that testing at the point of care meets the same accreditation and regulatory requirements as the central laboratory.
It is the responsibility of Biomedical Laboratory Scientists to ensure the quality of all Point of Care Testing that falls under the jurisdiction of their laboratory regardless of where testing is performed.
Only qualified, trained and fully competent personnel may perform point of care laboratory testing.
The test menu should include only those tests that are clinically relevant for point of care and those tests should be performed only when action is taken immediately as a result of data obtained. Tests on the Point of Care Testing menu should be reviewed periodically for clinical need and effectiveness.

Biomedical laboratory scientists have the responsibility for the management of Point of Care Testing Programs by providing leadership and expertise in:

  • selecting and approving instrumentation,
  • developing standard operating procedures for performing Point of Care Testing,
  • developing, maintaining and reviewing appropriate training programs to ensure competency of laboratory personnel,
  • establishing and monitoring internal and external quality assessment programs,
  • educating and training users on testing performance and quality assurance methodologies,
  • establishing instrument maintenance systems, incident reporting, risk management and record keeping of quality and patient data,
  • establishing and monitoring appropriate documentation of all aspect of the Point of Care Testing program,
  • communicating and educating patients, when relevant, on testing methodologies and interpretation of their results.

This position paper does not cover patient self-testing.

References:

  • ISO 15189:2012 Medical laboratories – Requirements for quality and competence
  • ISO 22870:2006 Point-of-care testing (POCT) – Requirements for quality and competence.

View the IFBLS Position Paper on Point of Care Testing (2018)  

View the IFBLS Guidelines on Point of Care testing (2010)
View the EPBS and IFBLS Policy Statement on Point of Care Testing (2010)

 

IFBLS Position Paper - Patient Safety

The World Health Organization identified patient safety as a global health priority in 2002.1 This goal was reaffirmed in 2019, with detailed recommendations for global action to improve patient safety.2

The foundation of patient safety is 'First do no harm'. Improving patient safety requires preventing and reducing errors, and constantly mitigating and avoiding unsafe acts. Patient safety requires that health care delivery is safe, effective, patient-centered, timely, efficient and equitable.3 Safe healthcare delivery requires all healthcare professionals to assure quality processes and use evidence in their practice, continuously improve processes, incorporate current information technology, work in interprofessional teams to deliver patient (person)-centered care.4

IFBLS recommends that the education and training of Biomedical Laboratory Scientists comprises both tertiary education and a minimum supervised clinical laboratory experience to achieve the required standard of practice in order to carry out the following key aspects of their role; to promote safe, effective, efficient, timely, patient-centered and equitable clinical laboratory services to support diagnosis, treatment and health care for patients.

It is the position of IFBLS that:

Biomedical Laboratory Scientists are responsible for ensuring the safety of each step of the laboratory testing process by: 

  • Adhering to current high standards of practice and the application of quality assured protocols and governance;
  • Focusing upon preventing errors in the entire laboratory testing process;
  • Ensuring that laboratories conform with national and international standards of accreditation;
  • Maintaining high standards for qualifications and continuing professional development;
  • Including patient safety concepts and competencies into academic and continuing professional development requirements for Biomedical Laboratory Scientists;
  • Improving laboratory testing services applying continuous quality improvement principles. 

Biomedical Laboratory Scientists are responsible for the effectiveness of laboratory testing by: 

  • Incorporating current scientific evidence of appropriate use of laboratory testing;
  • Ensuring optimal use of laboratory testing services as an aide to diagnosis, and monitoring treatment of disease.
  • Improving appropriate utilization of existing and new technology to optimize the benefits of laboratory investigations.

Biomedical Laboratory Scientists are responsible for improving the efficiency of laboratory testing in all settings by:

  • Using cost effective methods for all processes without compromising standards;
  • Eliminating defects in the total laboratory testing process through audit and quality assurance.
  • Improving workforce productivity with technology, informatics and continuous review and evaluation of processes.

Biomedical Laboratory Scientists are responsible for ensuring the timeliness of laboratory testing in all settings by:

  • Employing analytical test methods that use optimal procedures and technology.
  • Using new technology and informatics to optimize delivery of laboratory results and interpretative information to ensure maximum benefit to the patient.

Biomedical Laboratory Scientists are responsible for equity in the delivery of laboratory testing services by:

  • Ensuring access to laboratory testing services for all individuals based on clinical need;
  • Evaluating access to laboratory services with a monitoring system.         

Biomedical Laboratory Scientists are responsible for providing laboratory testing services that are patient-centered by:

  • Maintaining patient confidentiality throughout all phases of laboratory testing;
  • Providing patients with information about laboratory testing prior to specimen collection in order to give informed consent;
  • Providing test results and interpretation to inform the diagnosis;
  • Focusing on improving patient outcomes using new technologies, such as personalized medicine by contributing our professional expertise.

 

References:

  1. World Health Organization. Patient safety: a global health priority. Retrieved from: http://apps.who.int/gb/archive/pdf_files/WHA55/ewha5518.pdf?ua=1&ua=1
  1. World Health Organization. Global action on patient Safety. Retrieved from: http://apps.who.int/gb/ebwha/pdf_files/WHA72/A72_R6-en.pdf?ua=1
  1. Committee on Quality of Health Care in America. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press; 2001.
  2. Committee on the Health Professions Summit. Institute of Medicine. Health Professions Education, a Bridge to Quality. Washington, DC; National Academies Press; 2003.

 

IFBLS Position Paper on Patient Safety was adopted by the IFBLS GAD 2020

View the IFBLS Position Paper on Patient Safety (2020)